标题
Update on FXR Biology: Promising Therapeutic Target?
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 2069
出版商
MDPI AG
发表日期
2018-07-16
DOI
10.3390/ijms19072069
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
- (2018) O. Erice et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
- (2018) Vittoria Massafra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice
- (2018) Caixia Yan et al. BIOMEDICINE & PHARMACOTHERAPY
- Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction
- (2018) Yunlong Xia et al. CARDIOVASCULAR RESEARCH
- Farnesoid X receptor modulators 2014-present: a patent review
- (2018) Valentina Sepe et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis
- (2018) Michael D. Thompson et al. HEPATOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice
- (2018) Xiaoying Liu et al. HEPATOLOGY
- Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
- (2018) Phillipp Hartmann et al. HEPATOLOGY
- INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
- (2018) Paolo Comeglio et al. JOURNAL OF ENDOCRINOLOGY
- HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter
- (2018) Xin Xu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation
- (2018) Zhibo Gai et al. MOLECULAR PHARMACOLOGY
- Farnesoid X receptor antagonist exacerbates dyslipidemia in mice
- (2018) Yuichiro Amano et al. Pharmacological Reports
- Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand
- (2018) Adriana Carino et al. PHARMACOLOGICAL RESEARCH
- Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress
- (2018) Sujuan Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
- (2018) Jonathan D Roth et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
- (2018) Kavita Jadhav et al. Molecular Metabolism
- A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism
- (2017) Shujun Xie et al. FEBS LETTERS
- Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
- (2017) Jan Freark de Boer et al. GASTROENTEROLOGY
- Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice
- (2017) Vittoria Massafra et al. GASTROENTEROLOGY
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated
- (2017) Lindsey Kennedy et al. HEPATOLOGY
- Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis
- (2017) Yongdong Niu et al. HEPATOLOGY
- Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
- (2017) Kang Ho Kim et al. HEPATOLOGY
- Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice
- (2017) Oludemilade Akinrotimi et al. HEPATOLOGY
- A dual agonist of farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
- (2017) Preeti Pathak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
- (2017) Mei Zhou et al. JOURNAL OF HEPATOLOGY
- Steroidal or non-steroidal FXR agonists – Is that the question?
- (2017) Len Verbeke et al. JOURNAL OF HEPATOLOGY
- The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
- (2017) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of FXR pathway does not alter glial cell function
- (2017) Stefanie Albrecht et al. Journal of Neuroinflammation
- FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
- (2017) Xiaoxin X. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
- (2017) Andi Marquardt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hepatocyte Nuclear Factor–1βRegulates Urinary Concentration and Response to Hypertonicity
- (2017) Karam Aboudehen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity
- (2017) Yi Lu et al. MOLECULAR PHARMACOLOGY
- Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor
- (2017) Zhihui Zheng et al. MOLECULAR PHARMACOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Alisol B 23-acetate from the rhizomes of Alisma orientale is a natural agonist of the human pregnane X receptor
- (2017) Yuichiro Kanno et al. PHYTOMEDICINE
- Editor’s Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway
- (2017) Shogo Takahashi et al. TOXICOLOGICAL SCIENCES
- Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
- (2017) Yimeng Zhang et al. TOXICOLOGY
- Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner
- (2017) Wenxuan Xu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
- (2017) Pedro M Rodrigues et al. Cell Death & Disease
- Activation of Sirt1/FXR Signaling Pathway Attenuates Triptolide-Induced Hepatotoxicity in Rats
- (2017) Jing Yang et al. Frontiers in Pharmacology
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1
- (2017) Wenjie You et al. Scientific Reports
- Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation
- (2017) Lili Sheng et al. Scientific Reports
- Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
- (2017) Zhibo Gai et al. Scientific Reports
- Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation
- (2016) Qiang Meng et al. ACTA PHARMACOLOGICA SINICA
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Farnesoid X Receptor and Its Ligands Inhibit the Function of PlateletsHighlights
- (2016) Leonardo A. Moraes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
- (2016) Nicole M. Kettner et al. CANCER CELL
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- FXR Agonists: From Bench to Bedside, a Guide for Clinicians
- (2016) Ahmad Samer Alawad et al. DIGESTIVE DISEASES AND SCIENCES
- Dihydroartemisinin counteracts fibrotic portal hypertensionviafarnesoid X receptor-dependent inhibition of hepatic stellate cell contraction
- (2016) Wenxuan Xu et al. FEBS Journal
- Identification of functional farnesoid X receptors in brain neurons
- (2016) Chao Huang et al. FEBS LETTERS
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis
- (2016) Supriya R. Kulkarni et al. HEPATOLOGY
- Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism
- (2016) Wenxuan Xu et al. IUBMB LIFE
- Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor
- (2016) Ming Gu et al. Frontiers in Pharmacology
- Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming
- (2016) Yang Xie et al. Scientific Reports
- Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation
- (2016) Fan Yang et al. Scientific Reports
- Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
- (2016) Kai Zhao et al. Scientific Reports
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice
- (2015) Wei-Bin Wu et al. BIOCHIMIE
- Role of FXR in β-Cells of Lean and Obese Mice
- (2015) Björn Schittenhelm et al. ENDOCRINOLOGY
- AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor
- (2015) Eun Hye Jung et al. EUROPEAN JOURNAL OF NUTRITION
- Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes
- (2015) Chunfeng Lu et al. IUBMB LIFE
- Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice
- (2015) Zhibo Gai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Implications of microbiota and bile acid in liver injury and regeneration
- (2015) Hui-Xin Liu et al. JOURNAL OF HEPATOLOGY
- Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance
- (2015) Mohamed Sham Shihabudeen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis
- (2015) FAN LIAN et al. Molecular Medicine Reports
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice
- (2015) Qiang Meng et al. PHARMACEUTICAL RESEARCH
- Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis
- (2015) Qiang Meng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Protective effects of alisol B 23-acetate from edible botanical Rhizoma alismatis against carbon tetrachloride-induced hepatotoxicity in mice
- (2015) Qiang Meng et al. Food & Function
- FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach
- (2015) Weiqiang Lu et al. Scientific Reports
- Obeticholic acid for the treatment of primary biliary cirrhosis
- (2015) Palak J Trivedi et al. Expert Review of Clinical Pharmacology
- Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
- (2015) Guodong Li et al. Acta Pharmaceutica Sinica B
- FXR and liver carcinogenesis
- (2014) Xiong-fei Huang et al. ACTA PHARMACOLOGICA SINICA
- Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction
- (2014) Xijun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor
- (2014) Qiang Meng et al. BIOCHEMICAL PHARMACOLOGY
- Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation
- (2014) Chiara Degirolamo et al. HEPATOLOGY
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner
- (2014) Eun Hui Bae et al. PLoS One
- Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
- (2014) Rian M. Nijmeijer et al. PLoS One
- Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
- (2014) Sharon Manley et al. Redox Biology
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
- (2013) Lars P. Bechmann et al. HEPATOLOGY
- SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
- (2013) Juan L. García-Rodríguez et al. HEPATOLOGY
- Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice
- (2013) Guodong Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- FXR ligands protect against hepatocellular inflammation via SOCS3 induction
- (2012) Zhizhen Xu et al. CELLULAR SIGNALLING
- Farnesoid X Receptor Protects Hepatocytes From Injury by Repressing miR-199a-3p, Which Increases Levels of LKB1
- (2012) Chan Gyu Lee et al. GASTROENTEROLOGY
- Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice
- (2012) Lisheng Zhang et al. HEPATOLOGY
- Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice
- (2012) Zhipeng Meng et al. JOURNAL OF HEPATOLOGY
- Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis
- (2012) Barbara Renga et al. PLoS One
- The significance of the nuclear farnesoid X receptor (FXR) in β cell function
- (2012) Martina Düfer et al. Islets
- Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter
- (2011) Barbara Renga et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Nuclear receptors in renal disease
- (2011) Moshe Levi BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X receptor agonists for primary biliary cirrhosis
- (2011) Keith D Lindor CURRENT OPINION IN GASTROENTEROLOGY
- Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
- (2011) Salvatore Modica et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts
- (2011) Barbara Renga et al. INFLAMMATION RESEARCH
- Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
- (2011) J. Li et al. MOLECULAR PHARMACOLOGY
- Hepatic FXR: key regulator of whole-body energy metabolism
- (2011) João Soeiro Teodoro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The bile acid sensor FXR regulates insulin transcription and secretion
- (2010) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Nuclear bile acid receptor FXR in the hepatic regeneration
- (2010) Wei-Dong Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
- (2010) Iuliana Ristea Popescu et al. FEBS LETTERS
- Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1
- (2010) Henriette E. Meyer zu Schwabedissen et al. HEPATOLOGY
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
- (2010) Sayeepriyadarshini Anakk et al. JOURNAL OF CLINICAL INVESTIGATION
- FXR Regulates Liver Repair after CCl4-Induced Toxic Injury
- (2010) Zhipeng Meng et al. MOLECULAR ENDOCRINOLOGY
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
- (2010) Jiang Li et al. PLoS One
- Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
- (2009) Peter Fickert et al. AMERICAN JOURNAL OF PATHOLOGY
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
- (2009) Jongsook Kim Kemper et al. Cell Metabolism
- Farnesoid X receptor agonists in biliary tract disease
- (2009) Stefano Fiorucci et al. CURRENT OPINION IN GASTROENTEROLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
- (2008) S. Modica et al. CANCER RESEARCH
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis
- (2008) Young Joo Park et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started